rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
AstraZeneca Pharma India Ltd. - Research Center
506820 ASTRAZEN Group (A) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Annual results in brief
(Rs crore)
Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19 Mar ' 18
Sales 805.60 813.56 831.81 728.29 571.00
Operating profit 86.17 135.47 120.69 71.30 46.29
Interest 0.95 1.09 1.14 - -
Gross profit 99.99 147.22 132.54 87.59 58.54
EPS (Rs) 24.64 37.32 28.88 21.78 10.37
Annual  results in details
Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19 Mar ' 18
Other income 14.76 12.84 12.99 16.29 12.25
Stock adjustment 14.47 2.95 -39.21 -1.38 -51.00
Raw material 89.61 97.26 70.21 62.67 27.88
Power and fuel - - - - -
Employee expenses 230.21 219.54 216.70 197.40 153.53
Excise - - - - -
Admin and selling expenses - 45.21 55.76 79.80 72.81
Research and development expenses - - - - -
Expenses capitalised - - - - -
Other expenses 385.14 313.14 407.66 318.50 321.49
Provisions made - - - - -
Depreciation 16.95 20.13 18.58 14.92 14.74
Taxation 21.44 33.79 41.75 18.22 17.89
Net profit / loss 61.59 93.30 72.21 54.44 25.91
Extra ordinary item - - - - -
Prior year adjustments - - - - -
Equity capital 5.00 5.00 5.00 5.00 5.00
Equity dividend rate - - - - -
Agg.of non-prom. shares (Lacs) - - - - -
Agg.of non promotoholding (%) - - - - -
OPM (%) 10.70 16.65 14.51 9.79 8.11
GPM (%) 12.19 17.81 15.69 11.76 10.04
NPM (%) 7.51 11.29 8.55 7.31 4.44

Mutual Fund Selector

Find the fund that is right for you
Close
Add AstraZeneca Pharma India Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add AstraZeneca Pharma India Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close